Nitrase Therapeutics

2 known investors

Nitrase Therapeutics develops medicines based on nitrases, a class of enzymes it discovered that are involved in a range of diseases. Its proprietary NITROME platform studies protein nitration to identify nitrases and their substrates and develop novel therapeutics.